EcoDrugPlus

Ensembl ID : ENSUPAG00010017953
Gene Symbol: -
Cross references: -
129 Possible Orthologues:

Ensembl ID : ENSUPAG00010017952
Gene Symbol: -
Cross references: -
129 Possible Orthologues:

Ensembl ID : ENSUPAG00010011963
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSUPAG00010009459
Gene Symbol: -
Cross references: -
265 Possible Orthologues:

Ensembl ID : ENSUPAG00010005456
Gene Symbol: -
Cross references: -
171 Possible Orthologues:

Ensembl ID : ENSUPAG00010023476
Gene Symbol: -
Cross references: -
279 Possible Orthologues:

Ensembl ID : ENSUPAG00010008122
Gene Symbol: -
Cross references: -
623 Possible Orthologues:

Ensembl ID : ENSUPAG00010011110
Gene Symbol: -
Cross references: -
94 Possible Orthologues:

Ensembl ID : ENSUPAG00010010678
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSUPAG00010006160
Gene Symbol: -
Cross references: -
74 Possible Orthologues:

Ensembl ID : ENSUPAG00010011453
Gene Symbol: -
Cross references: -
318 Possible Orthologues:

Ensembl ID : ENSUPAG00010002397
Gene Symbol: -
Cross references: -
218 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).